Artificial intelligence (AI) is not just a futuristic concept anymore and confined to Silicon Valley hype. It is currently reshaping the healthcare industry widely. It is enhancing patient care and improving quality of human life. OpenAI CEO Sam Altman lately declared onset of the “Intelligence Age.” Critics are viewing such proclamations as overly optimistic. But ground reality reveals a different story.
GE Verisound AI is making possible for non-experts to capture high-quality ultrasound images of the heart. Such a task was earlier limited only to trained professionals. The new technology is about convenience and also about speeding up disease detection. It of course potentially saves lives.
Drug discovery is another area where the impact of AI is undeniable. AtomNet platform from the stable of Atomwise is using AI to predict drug efficacy before clinical trials. It identified novel drug candidates for hundreds of targets earlier this year and managed in reducing time as well as financial burden of bringing life-saving drugs to market dramatically. It is being viewed as a game-changer and especially for rare diseases.
Radiology is also undergoing a transformation. AI tools like Behold.ai’s “red dot” algorithm is cutting diagnostic times and reducing the workloads of radiologists. The systems can process images faster and more accurately compared to humans. It can potentially catch abnormalities easily.
The advancements in speech recognition, clinical decision-making and automated healthcare delivery are proof of the potential of AI. Companies like Voiceitt and Merative are offering AI-driven solutions and enhancing accessibility for individuals with speech impairments and assist clinicians.
WELL Health Technologies is the largest outpatient clinic operator in Canada. Its AI-powered automation is streamlining healthcare operations and allowing clinicians to focus on patient care.
